S0003654

FTC 200mg+TDF 300mg tabs/PAC-30


Emtricitabine 200mg + Tenofovir disoproxil fumarate 300mg, equivalent to 245mg Tenofovir disoproxil, film coated tablets, in bottle pack of 30
Indicative Price : Upon Request

NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org

General Description:
Emtricitabine 200mg + Tenofovir 300mg Tablets, pack of 30

Technical Specifications:
Each film coated tablet contains Emtricitabine 200mg and Tenofovir Disoproxil Fumarate 300mg which is equivalent to 245mg of Tenofovir Disoproxil as fixed dose combination (FDC).

Therapeutic class:
Emtricitabine is a Nucleoside Reverse Transcriptase Inhibitor (NRTI)
Tenofovir is a Nucleotide Reverse Transcriptase Inhibitor (NtRTI)

Standard shelf life:
2 years (24 months)

Other available formulations:
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use:
For more details, please click the links listed below:

WHO treatment guidelines


and

WHO Essential Medicines Library


or your regional national guidelines

For details about paediatric dosage schemes, please click the links listed below:

WHO HIV/AIDS


WHO Generic tool for assessing paediatric ARV dosing


Indications:
Management of HIV-1 infection in adults in combination with at least one other antiretroviral drug. By mouth (oral), PO

Storage:
Do not store above 30ºC (86ºF).
Store in a tightly closed container.
Keep out of reach and sight of children.

Dispensing instructions:
Dispense in original container. Do not repack
Can be taken with or without food

Regulatory Status:
For latest updates, please click the links listed below:

List of WHO Prequalified Medicines


List of USFDA approved and tentatively approved items

Related Products